{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:16:32Z","timestamp":1788524192501,"version":"build-2803163510"},"reference-count":100,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Research Fund of Fujian Key Laboratory of Tumor Immunotherapy","award":["ZLMYZL-2025-01"],"award-info":[{"award-number":["ZLMYZL-2025-01"]}]},{"name":"FuXiaQuan National Independent Innovation Demonstration Zone Collaborative Innovation Platform Project","award":["2023FX0001"],"award-info":[{"award-number":["2023FX0001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digital"],"abstract":"<jats:p>Cancer has become a major global health threat due to its high incidence and mortality. However, the development of anti-cancer drugs is limited by high costs, long cycles, and low success rates, slowing the progress of new treatments. As a method that simulates human cognitive functions, artificial intelligence (AI) has greatly improved the efficiency of drug development. Machine learning is a core part of AI and supports applications such as natural language processing and computer vision. This paper reviews recent advances in AI for optimizing anti-cancer drug discovery, development, and medication therapy management. First, we highlight the applications of AI in target identification, druggability assessment, drug screening, and repurposing. Second, we detail how AI optimizes drug combination therapy and clinical trial design. Finally, we describe the role of AI in treatment management, including nanoparticle delivery systems, personalized dosing, and adaptive therapy. AI greatly streamlines anti-cancer drug development and provides new directions for precision cancer therapy.<\/jats:p>","DOI":"10.3390\/digital6020032","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:10:44Z","timestamp":1776787844000},"page":"32","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Methods in Anti-Cancer Drug Discovery, Development, and Therapy Management: A Review"],"prefix":"10.3390","volume":"6","author":[{"given":"Jingyi","family":"Liu","sequence":"first","affiliation":[{"name":"College of Marine Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaer","family":"Cai","sequence":"additional","affiliation":[{"name":"College of Marine Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Yao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Mariculture Breeding, Key Laboratory of Marine Biotechnology of Fujian Province, Fujian Agriculture and Forestry University, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Marine Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Computer and Information Science, Department of Science and Engineering, Faculty of Science and Engineering, Iwate University, 4-3-5 Ueda, Morioka 020-8551, Iwate, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-632X","authenticated-orcid":false,"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Marine Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China"},{"name":"State Key Laboratory of Mariculture Breeding, Key Laboratory of Marine Biotechnology of Fujian Province, Fujian Agriculture and Forestry University, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41568-021-00399-1","article-title":"Artificial intelligence in cancer research, diagnosis and therapy","volume":"21","author":"Elemento","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: A review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif. Intell. Rev."},{"key":"ref_3","unstructured":"Russell, S., and Norvig, P. (2020). Artificial Intelligence: A Modern Approach, Pearson. [4th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/radiol.2016150063","article-title":"Low-Dose CT Screening for Lung Cancer: Computer-aided Detection of Missed Lung Cancers","volume":"281","author":"Liang","year":"2016","journal-title":"Radiology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Begines, B., Ortiz, T., P\u00e9rez-Aranda, M., Mart\u00ednez, G., Merinero, M., Arg\u00fcelles-Arias, F., and Alcudia, A. (2020). Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials, 10.","DOI":"10.3390\/nano10071403"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wu, J., Zhou, X.S., Shi, F., and Shen, D. (2023). Recent advancements in artificial intelligence for breast cancer: Image augmentation, segmentation, diagnosis, and prognosis approaches. Seminars in Cancer Biology, Academic Press.","DOI":"10.1016\/j.semcancer.2023.09.001"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","article-title":"Artificial intelligence in histopathology: Enhancing cancer research and clinical oncology","volume":"3","author":"Shmatko","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gogoshin, G., and Rodin, A.S. (2023). Graph Neural Networks in Cancer and Oncology Research: Emerging and Future Trends. Cancers, 15.","DOI":"10.20944\/preprints202310.1655.v1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106140","DOI":"10.1016\/j.compbiomed.2022.106140","article-title":"A comprehensive review on recent approaches for cancer drug discovery associated with artificial intelligence","volume":"150","author":"Pandiyan","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.tips.2019.09.004","article-title":"Has Drug Design Augmented by Artificial Intelligence Become a Reality?","volume":"40","author":"Chen","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"bbaa430","DOI":"10.1093\/bib\/bbaa430","article-title":"An end-to-end heterogeneous graph representation learning-based framework for drug-target interaction prediction","volume":"22","author":"Peng","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"bbac207","DOI":"10.1093\/bib\/bbac109","article-title":"DTI-HETA: Prediction of drug-target interactions based on GCN and GAT on heterogeneous graph","volume":"23","author":"Shao","year":"2022","journal-title":"Brief. Bioinform."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, L., Song, Y., Wang, H., Zhang, X., Wang, M., He, J., Li, S., Zhang, L., Li, K., and Cao, L. (2023). Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020253"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/acs.jpclett.1c00867","article-title":"ML-DTI: Mutual Learning Mechanism for Interpretable Drug-Target Interaction Prediction","volume":"12","author":"Yang","year":"2021","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: Background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s44386-025-00034-1","article-title":"A review of deep learning approaches for drug synergy prediction in cancer","volume":"2","author":"Li","year":"2025","journal-title":"npj Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"bbab355","DOI":"10.1093\/bib\/bbab355","article-title":"Machine learning methods, databases and tools for drug combination prediction","volume":"23","author":"Wu","year":"2022","journal-title":"Brief. Bioinform."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11427-023-2422-x","article-title":"Challenges and opportunities in rare cancer research in China","volume":"67","author":"Xue","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1097\/JS9.0000000000003040","article-title":"Navigating the digital health landscape from artificial intelligence-driven molecular subtyping towards optimized rare sarcoma trial design","volume":"111","author":"Wang","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2012.45.4553","article-title":"Patient income level and cancer clinical trial participation","volume":"31","author":"Unger","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2024.10.093","article-title":"The Coming AI Revolution in Clinical Trials","volume":"85","author":"Jain","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: A looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: Emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","article-title":"Circumventing cancer drug resistance in the era of personalized medicine","volume":"2","author":"Garraway","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103985","DOI":"10.1016\/j.drudis.2024.103985","article-title":"The present state and challenges of active learning in drug discovery","volume":"29","author":"Wang","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e25541","DOI":"10.1097\/MD.0000000000025541","article-title":"Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/omi.2017.0115","article-title":"Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer","volume":"21","author":"Gov","year":"2017","journal-title":"Omics"},{"key":"ref_34","first-page":"6066","article-title":"Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","article-title":"Deep learning in drug discovery: An integrative review and future challenges","volume":"56","author":"Askr","year":"2023","journal-title":"Artif. Intell. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaz3023","article-title":"Artificial intelligence in cancer therapy","volume":"367","author":"Ho","year":"2020","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.drudis.2014.10.012","article-title":"Machine-learning approaches in drug discovery: Methods and applications","volume":"20","author":"Lavecchia","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41598-020-58290-2","article-title":"Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics","volume":"10","author":"Sinkala","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/s41467-021-23774-w","article-title":"MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","article-title":"GraphDTA: Predicting drug-target binding affinity with graph neural networks","volume":"37","author":"Nguyen","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1093\/bioinformatics\/btab548","article-title":"DTI-Voodoo: Machine learning over interaction networks and ontology-based background knowledge predicts drug-target interactions","volume":"37","author":"Hinnerichs","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/bioinformatics\/btab191","article-title":"Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug-drug links based on graph neural network","volume":"37","author":"Cui","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102327","DOI":"10.1016\/j.sbi.2021.102327","article-title":"Graph neural network approaches for drug-target interactions","volume":"73","author":"Zhang","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/bib\/bby004","article-title":"Artificial intelligence in drug combination therapy","volume":"20","author":"Tsigelny","year":"2018","journal-title":"Brief. Bioinform."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/s41598-023-33271-3","article-title":"SYNDEEP: A deep learning approach for the prediction of cancer drugs synergy","volume":"13","author":"Torkamannia","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: Predicting anti-cancer drug synergy with Deep Learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/acs.jmedchem.3c02169","article-title":"Model-Based Virtual PK\/PD Exploration and Machine Learning Approach to Define PK Drivers in Early Drug Discovery","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent Drug Action in Combination Therapy: Implications for Precision Oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1038\/s41467-020-19563-6","article-title":"Computationally Predicting Clinical Drug Combination Efficacy with Cancer Cell Line Screens and Independent Drug Action","volume":"11","author":"Ling","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of Clinical Trial Success Rates and Related Parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors Associated with Clinical Trials that Fail and Opportunities for Improving the Likelihood of Success: A Review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The role of clinical trial participation in cancer research: Barriers, evidence, and strategies","volume":"35","author":"Unger","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jnci\/djz245","article-title":"The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design","volume":"112","author":"Flaherty","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41746-022-00603-y","article-title":"Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion","volume":"5","author":"Goodson","year":"2022","journal-title":"npj Digit. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","article-title":"Artificial Intelligence for Clinical Trial Design","volume":"40","author":"Harrer","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-022-01102-1","article-title":"Clinical trial design in the era of precision medicine","volume":"14","author":"Fountzilas","year":"2022","journal-title":"Genome Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e18598","DOI":"10.1200\/JCO.2018.36.15_suppl.e18598","article-title":"Clinical performance pilot using cognitive computing for clinical trial matching at Mayo Clinic","volume":"36","author":"Helgeson","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"0048","DOI":"10.34133\/bmef.0048","article-title":"Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling","volume":"5","author":"Selcuk","year":"2024","journal-title":"BME Front."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41746-022-00613-w","article-title":"Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials","volume":"5","author":"Esteva","year":"2022","journal-title":"npj Digit. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e27767","DOI":"10.2196\/27767","article-title":"Accuracy of an Artificial Intelligence System for Cancer Clinical Trial Eligibility Screening: Retrospective Pilot Study","volume":"9","author":"Haddad","year":"2021","journal-title":"JMIR Med. Inform."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41746-018-0029-1","article-title":"Scalable and accurate deep learning with electronic health records","volume":"1","author":"Rajkomar","year":"2018","journal-title":"npj Digit. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1002\/sim.9491","article-title":"Deep reinforcement learning for personalized treatment recommendation","volume":"41","author":"Liu","year":"2022","journal-title":"Stat. Med."},{"key":"ref_64","unstructured":"Yauney, G., and Shah, P. (2018). Reinforcement Learning with Action-Derived Rewards for Chemotherapy and Clinical Trial Dosing Regimen Selection. Proceedings of the 3rd Machine Learning for Healthcare Conference, Journal of Machine Learning Research. Proceedings of Machine Learning Research."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically Applicable Deep Learning for Diagnosis and Referral in Retinal Disease","volume":"24","author":"Ledsam","year":"2018","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jnci\/djy222","article-title":"Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison with 101 Radiologists","volume":"111","author":"Lang","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1016\/j.jksuci.2021.06.005","article-title":"IoT and artificial intelligence implementations for remote healthcare monitoring systems: A survey","volume":"34","author":"Mazin","year":"2022","journal-title":"J. King Saud Univ. Comput. Inf. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1002\/widm.1485","article-title":"Remote Patient Monitoring Using Artificial Intelligence: Current State, Applications, and Challenges","volume":"13","author":"Shaik","year":"2023","journal-title":"WIREs Data Min. Knowl. Discov."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","article-title":"Smart Drug Delivery Systems for Precise Cancer Therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric Nanoparticles for Drug Delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/IJN.S344208","article-title":"Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches","volume":"17","author":"Lin","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_72","unstructured":"Ding, D.Y., Zhang, Y., Jia, Y., and Sun, J. (2023). Machine learning-guided lipid nanoparticle design for mRNA delivery. arXiv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1208\/s12249-023-02609-5","article-title":"Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin\/Chitosan Nanoparticles of a Poorly Water-Soluble Drug","volume":"24","author":"Dawoud","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41524-021-00614-5","article-title":"Evolutionary Computational Platform for the Automatic Discovery of Nanocarriers for Cancer Treatment","volume":"7","author":"Stillman","year":"2021","journal-title":"npj Comput. Mater."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"an Artificial Intelligence-Assisted Physiologically-Based Pharmacokinetic Model to Predict Nanoparticle Delivery to Tumors in Mice","volume":"361","author":"Chou","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"24010003","DOI":"10.69598\/sehs.18.24010003","article-title":"AI-driven design and optimization of nanoparticle-based drug delivery systems","volume":"18","author":"Kapoor","year":"2024","journal-title":"Sci. Eng. Health Stud."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11096-013-9912-7","article-title":"Cisplatin dose Adjustment In Patients with Renal Impairment, Which Recommendations Should We Follow?","volume":"36","author":"Bennis","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1120009X.2024.2349444","article-title":"Irinotecan Dosing and Pharmacogenomics: A Comprehensive Exploration Based on Ugt1a1 Variants and Emerging Insights","volume":"37","author":"Faisal","year":"2025","journal-title":"J. Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40262-024-01409-9","article-title":"Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review","volume":"63","author":"Teplytska","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Yu, Z., Ye, X., Liu, H., Li, H., Hao, X., Zhang, J., Kou, F., Wang, Z., Wei, H., and Gao, F. (2022). Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.893966"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cauvin, C., Bourguignon, L., Carriat, L., Mence, A., Ghipponi, P., Salas, S., and Ciccolini, J. (2022). Machine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112509"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-statistics-031219-041220","article-title":"Q-Learning: Theory and Applications","volume":"7","author":"Clifton","year":"2020","journal-title":"Annu. Rev. Stat. Appl."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmpb.2019.03.004","article-title":"Reinforcement Learning-Based Control of Tumor Growth Under Anti-Angiogenic Therapy","volume":"173","author":"Yazdjerdi","year":"2019","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mbs.2017.08.004","article-title":"Reinforcement Learning-Based Control of Drug Dosing For Cancer Chemotherapy Treatment","volume":"293","author":"Padmanabhan","year":"2017","journal-title":"Math. Biosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/psp4.12727","article-title":"Erdafitinib\u2019s Effect on Serum Phosphate Justifies its Pharmacodynamically Guided Dosing in Patients with Cancer","volume":"11","author":"Dosne","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Huo, L., and Tang, Y.P. (2023). Multi-Objective Deep Reinforcement Learning for Personalized dose Optimization Based on Multi-Indicator Experience Replay. Appl. Sci., 13.","DOI":"10.3390\/app13010325"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17347","DOI":"10.1007\/s00500-023-08068-1","article-title":"Reinforcement Learning Optimal Control with Semi-Continuous Reward Function and Fuzzy-Rules Networks for Drug Administration of Cancer Treatment","volume":"27","author":"Treesatayapun","year":"2023","journal-title":"Soft Comput."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Alsaadi, F.E., Yasami, A., Volos, C., Bekiros, S., and Jahanshahi, H. (2023). A New Fuzzy Reinforcement Learning Method for Effective Chemotherapy. Mathematics, 11.","DOI":"10.3390\/math11020477"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/psp4.12588","article-title":"Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncology","volume":"10","author":"Maier","year":"2021","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2472630319890316","article-title":"CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence","volume":"25","author":"Blasiak","year":"2020","journal-title":"SLAS Technol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/2211068216681979","article-title":"Optimizing Combination Therapy for Acute Lymphoblastic Leukemia Using a Phenotypic Personalized Medicine Digital Health Platform: Retrospective Optimization Individualizes Patient Regimens to Maximize Efficacy and Safety","volume":"22","author":"Lee","year":"2017","journal-title":"SLAS Technol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1800104","DOI":"10.1002\/adtp.201800104","article-title":"Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform","volume":"1","author":"Pantuck","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: Opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_94","first-page":"327ra324","article-title":"Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer","volume":"8","author":"Kam","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Majcher, U., Klejborowska, G., Moshari, M., Maj, E., Wietrzyk, J., Bartl, F., Tuszynski, J.A., and Huczynski, A. (2018). Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives. Cells, 7.","DOI":"10.3390\/cells7110192"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Garcia-Oliveira, P., Otero, P., Pereira, A.G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., and Prieto, M.A. (2021). Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals, 14.","DOI":"10.3390\/ph14020157"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1038\/s41598-019-49764-z","article-title":"NeuRiPP: Neural network identification of RiPP precursor peptides","volume":"9","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Digital"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-6470\/6\/2\/32\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:54:01Z","timestamp":1778522041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-6470\/6\/2\/32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["digital6020032"],"URL":"https:\/\/doi.org\/10.3390\/digital6020032","relation":{},"ISSN":["2673-6470"],"issn-type":[{"value":"2673-6470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}